CVS Caremark PT Raised to $85.00 at Morgan Stanley (CVS)
Equities research analysts at Morgan Stanley raised their target price on shares of CVS Caremark (NYSE:CVS) from $81.00 to $85.00 in a research note issued to investors on Wednesday. Morgan Stanley’s target price suggests a potential upside of 10.35% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at Barclays raised their price target on shares of CVS Caremark from $85.00 to $87.00 in a research note on Wednesday. Separately, analysts at Leerink Swann raised their price target on shares of CVS Caremark from $85.00 to $87.00 in a research note on Wednesday. Finally, analysts at Argus raised their price target on shares of CVS Caremark from $83.00 to $85.00 in a research note on Wednesday. They now have a “buy” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $80.48.
CVS Caremark (NYSE:CVS) traded down 0.31% on Wednesday, hitting $77.03. 11,306,321 shares of the company’s stock traded hands. CVS Caremark has a one year low of $56.32 and a one year high of $79.43. The stock has a 50-day moving average of $76.91 and a 200-day moving average of $74.23. The company has a market cap of $90.356 billion and a P/E ratio of 19.68. CVS Caremark also was the recipient of unusually large options trading on Monday. Investors bought 7,359 put options on the company. This represents an increase of approximately 776% compared to the average volume of 840 put options.
CVS Caremark (NYSE:CVS) last released its earnings data on Tuesday, August 5th. The company reported $1.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter last year, the company posted $0.97 earnings per share. CVS Caremark’s revenue was up 10.7% compared to the same quarter last year. Analysts expect that CVS Caremark will post $4.47 EPS for the current fiscal year.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.